Boehringer Ingelheim Pharma GmbH & Co. KG

Industry / private company


Location: Ingelheim am Rhein, Germany (DE) DE

ISNI: 0000000121717500

ROR: https://ror.org/00q32j219

Show on Map:


close-button

Types of publications

Journal article
Book chapter / Article in edited volumes
Authored book
Translation
Thesis
Edited Volume
Conference contribution
Other publication type
Unpublished / Preprint

Publication year

From
To

Abstract

Journal

Optimization of a drug transporter probe cocktail: potential screening tool for transporter-mediated drug-drug interactions (2018) Stopfer P, Giessmann T, Hohl K, Hutzel S, Schmidt S, Gansser D, Ishiguro N, et al. Journal article Biomarkers for In Vivo Assessment of Transporter Function (2018) Mueller F, Sharma A, König J, Fromm M Journal article Differences in kidney-specific DPP-4 inhibition by linagliptin and sitagliptin (2018) Luippold G, Mark M, Klein T, Amann KU, Daniel C Journal article Induction therapy with the selective interleukin-23 inhibitor risankizumab in patients with moderate-to-severe Crohn's disease: a randomised, double-blind, placebo-controlled phase 2 study (2017) Feagan BG, Sandborn WJ, D'Haens G, Panes J, Kaser A, Ferrante M, Louis E, et al. Journal article Early diagnosis of acute coronary syndrome (2017) Katus H, Ziegler A, Ekinci O, Giannitsis E, Stough WG, Achenbach S, Blankenberg S, et al. Journal article Nintedanib macrophage activation and ameliorates vascular and fibrotic manifestations in the Fra2 mouse model of systemic sclerosis (2017) Huang J, Maier C, Zhang Y, Soare A, Dees C, Beyer C, Harre U, et al. Journal article The F-actin modifier villin regulates insulin granule dynamics and exocytosis downstream of islet cell autoantigen 512 (2016) Mziaut H, Mulligan B, Hoboth P, Otto O, Ivanova A, Herbig M, Schumann D, et al. Journal article European Cooperative Acute Stroke Study-4: Extending the time for thrombolysis in emergency neurological deficits ECASS-4: ExTEND (2016) Amiri H, Bluhmki E, Bendszus M, Eschenfelder CC, Donnan GA, Leys D, Molina C, et al. Journal article Dopaminergic lesioning impairs adult hippocampal neurogenesis by distinct modification of α-synuclein (2016) Schlachetzki J, Grimm T, Schlachetzki Z, Ben Abdallah NMB, Ettle B, Voehringer P, Ferger B, et al. Journal article Nintedanib inhibits fibroblast activation and ameliorates fibrosis in preclinical models of systemic sclerosis (2015) Huang J, Beyer C, Palumbo-Zerr K, Zhang Y, Distler A, Gelse K, Distler O, et al. Journal article